- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Bharat Serums and Vaccines to buy Firstline Pharma, Genomicks to expand presence in women's health in Malaysia
New Delhi: Bharat Serums and Vaccines Limited (BSV), a biopharmaceutical company in India has entered into a definitive agreement to acquire Firstline Pharmaceuticals Sdn. Bhd and Genomicks Sdn Bhd, to augment its presence in women's health and reproductive therapy in Malaysia.
Following the acquisition, the two companies will be held by BSV. Incorporated in 2007, Firstline Pharmaceuticals Sdn. Bhd. is the distributor of fertility treatment in Malaysia. Genomicks Sdn Bhd was incorporated in 2016 and currently distributes medical devices in Malaysia. The companies distribute a wide range of products which include Foliculin, Hucog, Humog, Profortil, Fortelle+Omega 3.
Speaking on the acquisition, Rahul Adakmol, COO-International Operations, BSV, said "We continue to remain one of the few Indian biopharma majors with a strong global footprint. We are delighted to acquire Firstline Pharmaceuticals Sdn. Bhd and Genomicks Sdn Bhd as this accelerates our business goal of deepening our presence in South-East Asia. Keeping women at the core of our business activities, we are committed to bringing our broad portfolio of treatment options, devices, and advanced fertility treatments, which deliver improved health outcomes and have a measurable impact on their wellbeing."
"We are delighted with this partnership with BSV as this not only expands BSV's offerings in women's health but most importantly, works towards bringing more products that will improve the lives of women in Malaysia. Over the years, we have established our presence in Malaysia and have played a critical role in bringing safer treatments and cures to our people. We are confident that this partnership will open opportunities in growing BSV's presence in other business segments" said Logen Singam and Chitra Santhirarajan, Founders- Firstline Pharmaceuticals Sdn. Bhd and Genomicks Sdn Bhd, Malaysia.
Read also: Bharat Serums and Vaccines bags exclusive right to market severe burns treatment NexoBrid in India
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751